{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:52:46Z","timestamp":1793433166355,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100021201","name":"European Academy of Dermatology and Venereology","doi-asserted-by":"publisher","award":["PPRC-2020-21"],"award-info":[{"award-number":["PPRC-2020-21"]}],"id":[{"id":"10.13039\/501100021201","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RA-1026\/3-2"],"award-info":[{"award-number":["RA-1026\/3-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STA 1159\/4-2"],"award-info":[{"award-number":["STA 1159\/4-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STA 1159\/6-2"],"award-info":[{"award-number":["STA 1159\/6-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jaci.2023.04.018","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T16:48:18Z","timestamp":1683823698000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Clinical aspects and management of chronic itch"],"prefix":"10.1016","volume":"152","author":[{"given":"Claudia","family":"Zeidler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Raap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2023.04.018_bib1","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1172\/JCI28553","article-title":"Frontiers in pruritus research: scratching the brain for more effective itch therapy","volume":"116","author":"Paus","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2023.04.018_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2340\/00015555-3164","article-title":"European S2k guideline on chronic pruritus","volume":"99","author":"Weisshaar","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2340\/00015555-2166","article-title":"Prevalence and characteristics of pruritus: a one-week cross-sectional study in a German dermatology practice","volume":"96","author":"Kopyciok","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib4","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1111\/jdv.17485","article-title":"Prevalence, incidence and presence of comorbidities in patients with prurigo and pruritus in Germany: a population-based claims data analysis","volume":"35","author":"Augustin","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jdin.2020.10.009","article-title":"Prevalence of prurigo nodularis in the United States of America: a retrospective database analysis","volume":"2","author":"Stander","year":"2021","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaci.2023.04.018_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000319862","article-title":"Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730","volume":"221","author":"Stander","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2023.04.018_bib7","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v103.2922","article-title":"Association between pruritus and psychosocial well-being: a population-based study among 6,809 subjects","volume":"103","author":"Sinikumpu","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib8","first-page":"223","article-title":"Pruritus as reason for encounter in general practice","volume":"3","author":"Frese","year":"2011","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.jaci.2023.04.018_bib9","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.1063","article-title":"Prevalence of itch in German schoolchildren: a population-based study","volume":"102","author":"Theodosiou","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-4632.2005.02607.x","article-title":"The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients","volume":"45","author":"Yalcin","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib11","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1001\/jama.2013.282023","article-title":"Pruritus in the older patient: a clinical review","volume":"310","author":"Berger","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2023.04.018_bib12","first-page":"98","article-title":"Racial and gender differences in the presentation of pruritus","volume":"6","author":"Whang","year":"2019","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.jaci.2023.04.018_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/bjd.21021","article-title":"Body dysmorphia in common skin diseases: results of an observational, cross-sectional multicentre study among dermatological outpatients in 17 European countries","volume":"187","author":"Schut","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/jdv.16929","article-title":"The burden in chronic prurigo: patients with chronic prurigo suffer more than patients with chronic pruritus on non-lesional skin: a comparative, retrospective, explorative statistical analysis of 4,484 patients in a real-world cohort","volume":"35","author":"Zeidler","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib15","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/jid.2013.446","article-title":"The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions","volume":"134","author":"Hay","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jid.2020.08.020","article-title":"Health-related QOL and economic burden of chronic pruritus","volume":"141","author":"Whang","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib17","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/exd.13953","article-title":"How to define chronic pruritus: symptom or disease?","volume":"28","author":"Stander","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib18","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1152\/physrev.00017.2019","article-title":"Physiology and pathophysiology of itch","volume":"100","author":"Cevikbas","year":"2020","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jaci.2023.04.018_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000446009","article-title":"Classification of itch","volume":"50","author":"Stander","year":"2016","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib20","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archderm.139.11.1475","article-title":"Neurophysiology of pruritus: interaction of itch and pain","volume":"139","author":"Ikoma","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.det.2018.02.003","article-title":"Prurigo nodularis and its management","volume":"36","author":"Zeidler","year":"2018","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaci.2023.04.018_bib22","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/jdv.16360","article-title":"Opioid receptors expression in the skin of haemodialysis patients suffering from uraemic pruritus","volume":"34","author":"Wieczorek","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuron.2014.02.046","article-title":"Dynorphin acts as a neuromodulator to inhibit itch in the dorsal horn of the spinal cord","volume":"82","author":"Kardon","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.jaci.2023.04.018_bib24","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3390\/ijms24021559","article-title":"Pathogenesis and treatment of pruritus associated with chronic kidney disease and cholestasis","volume":"24","author":"Kim","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2023.04.018_bib25","article-title":"UPLC-QTOF MS-based serum metabolomic profiling analysis reveals the molecular perturbations underlying uremic pruritus","volume":"2018","author":"Wu","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jaci.2023.04.018_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129866","article-title":"Impaired itching perception in murine models of cholestasis is supported by dysregulation of GPBAR1 signaling","volume":"10","author":"Cipriani","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2023.04.018_bib27","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2010.05.009","article-title":"Lysophosphatidic acid is a potential mediator of cholestatic pruritus","volume":"139","author":"Kremer","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2023.04.018_bib28","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3892","article-title":"Chronic pruritus of unknown origin: clinical profile and disease-related burden","volume":"101","author":"Pereira","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2340\/00015555-0305","article-title":"Clinical classification of itch: a position paper of the International Forum for the Study of Itch","volume":"87","author":"Stander","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jdv.14570","article-title":"European Academy of Dermatology and Venereology European Prurigo Project: expert consensus on the definition, classification and terminology of chronic prurigo","volume":"32","author":"Pereira","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/17512433.2021.1852080","article-title":"Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis","volume":"14","author":"Williams","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jaci.2023.04.018_bib32","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/ddg.14830","article-title":"S2k guideline: diagnosis and treatment of chronic pruritus","volume":"20","author":"Stander","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaci.2023.04.018_bib33","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v103.4426","article-title":"Itching in atopic dermatitis: patient- and physician-reported outcomes in the German Atopic Dermatitis Registry TREATgermany","volume":"103","author":"Weisshaar","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/cea.14263","article-title":"The evolving landscape of biologic therapies for atopic dermatitis: present and future perspective","volume":"53","author":"David","year":"2023","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2023.04.018_bib35","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1002\/ski2.133","article-title":"Oral Janus kinase inhibitors in the treatment of atopic dermatitis: a systematic review and meta-analysis","volume":"3","author":"Lee","year":"2023","journal-title":"Skin Health Dis"},{"key":"10.1016\/j.jaci.2023.04.018_bib36","article-title":"Extracellular matrix and dermal nerve growth factor dysregulation in prurigo\u00a0nodularis compared to atopic dermatitis","volume":"9","author":"Deng","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2023.04.018_bib37","article-title":"Single-cell RNA sequencing reveals dysregulated fibroblast subclusters in prurigo nodularis","author":"Patel","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.jaci.2023.04.018_bib38","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.molmed.2022.03.005","article-title":"Cutaneous neuroimmune crosstalk in pruritus","volume":"28","author":"Agelopoulos","year":"2022","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaci.2023.04.018_bib39","article-title":"Dupilumab for the treatment of prurigo nodularis: a systematic review","volume":"14","author":"Cao","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2023.04.018_bib40","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/jdv.18377","article-title":"Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances","volume":"36","author":"Stander","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib41","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ckj\/sfab142","article-title":"Epidemiology and burden of chronic kidney disease\u2013associated pruritus","volume":"14","author":"Kim","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jaci.2023.04.018_bib42","series-title":"Uremic pruritus evaluation and treatment. Treasure Island","author":"Osakwe","year":"2022"},{"key":"10.1016\/j.jaci.2023.04.018_bib43","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.3390\/jcm11216292","article-title":"Elevated level of serum neurotrophin-4, but not of brain-derived neurotrophic factor, in patients with chronic kidney disease\u2013associated pruritus","volume":"11","author":"Wala-Zielinska","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaci.2023.04.018_bib44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/14656566.2020.1849142","article-title":"An evaluation of difelikefalin as a treatment option for moderate-to-severe pruritus in end stage renal disease","volume":"22","author":"Lipman","year":"2021","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaci.2023.04.018_bib45","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.clindermatol.2019.07.031","article-title":"Pruritus as a sign of systemic disease","volume":"37","author":"Welz-Kubiak","year":"2019","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib46","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2340\/00015555-2906","article-title":"Aquagenic pruritus in\u00a0polycythemia vera: clinical characteristics","volume":"98","author":"Lelonek","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.medcli.2019.10.004","article-title":"Chronic prurigo as a onset of Hodgkin\u2019s lymphoma","volume":"156","author":"Serra-Garcia","year":"2021","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.jaci.2023.04.018_bib48","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.04.018_bib49","article-title":"Neuropathic itch: routes to clinical diagnosis","volume":"8","author":"Pereira","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2023.04.018_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.det.2018.02.005","article-title":"Diagnosis and management of neuropathic itch","volume":"36","author":"Rosen","year":"2018","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaci.2023.04.018_bib51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5152\/alphapsychiatry.2022.21699","article-title":"Personality characteristics, anxiety sensitivity, anxiety, and depression levels on patients diagnosed with psychogenic pruritus","volume":"23","author":"Kazgan Kilicaslan","year":"2022","journal-title":"Alpha Psychiatry"},{"key":"10.1016\/j.jaci.2023.04.018_bib52","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/jdv.13296","article-title":"European\u00a0EADV\u00a0Network on Assessment of Severity and Burden of Pruritus (PruNet): first meeting on outcome tools","volume":"30","author":"Stander","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib53","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/jdv.17111","article-title":"Pruritus intensity scales across Europe: a prospective validation study","volume":"35","author":"Storck","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2016.08.009","article-title":"Assessment of severity and burden of pruritus","volume":"66","author":"Pereira","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2023.04.018_bib55","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1097\/itx.0000000000000042","article-title":"IFSI-guideline on chronic prurigo including prurigo nodularis","volume":"5","author":"St\u00e4nder","year":"2020","journal-title":"Itch"},{"key":"10.1016\/j.jaci.2023.04.018_bib56","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaad.2020.07.025","article-title":"Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus","volume":"84","author":"Elmariah","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib57","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/bjd.14910","article-title":"Chronic pruritus: evaluation of patient needs and treatment goals with a special regard to differences according to pruritus classification and sex","volume":"176","author":"Steinke","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib58","first-page":"e6","article-title":"Management of chronic pruritus: from the dermatological office to the specialized itch center: a review","volume":"2","author":"Pereira","year":"2017","journal-title":"Itch (Phila)"},{"key":"10.1016\/j.jaci.2023.04.018_bib59","first-page":"524","article-title":"Comparing the efficacy and safety of pregabalin vs gabapentin in uremic pruritus in patients of chronic kidney injury undergoing haemodialysis","volume":"34","author":"Khan","year":"2022","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"10.1016\/j.jaci.2023.04.018_bib60","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaad.2016.02.1237","article-title":"Gabapentin and pregabalin\u00a0for the treatment of chronic pruritus","volume":"75","author":"Matsuda","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib61","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1523\/JNEUROSCI.21-06-01868.2001","article-title":"Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its\u00a0correlation with allodynia in spinal nerve-injured rats","volume":"21","author":"Luo","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.jaci.2023.04.018_bib62","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/jamadermatol.2021.3829","article-title":"Improvement of chronic kidney disease\u2013associated pruritus after treatment with intravenous naloxone","volume":"157","author":"Pereira","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib63","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1111\/jdv.18553","article-title":"Brachioradial pruritus successfully treated with intravenous naloxone","volume":"37","author":"Zeidler","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib64","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/jdv.17816","article-title":"Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open-label extension phase","volume":"36","author":"Weisshaar","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib65","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000355671","article-title":"Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial","volume":"227","author":"Siepmann","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2023.04.018_bib66","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1067\/mjd.2001.110059","article-title":"Treatment of prurigo nodularis with topical capsaicin","volume":"44","author":"Stander","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib67","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1365-4632.2010.04537.x","article-title":"Systematic review of topical capsaicin in the treatment of pruritus","volume":"49","author":"Gooding","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib68","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaad.2016.07.016","article-title":"Research letter: impact of pruritus on\u00a0quality of life\u2014a systematic review","volume":"75","author":"Kantor","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib69","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000437206","article-title":"Health-related quality of life in chronic pruritus: an analysis related to disease\u00a0etiology, clinical skin conditions and itch intensity","volume":"231","author":"Warlich","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2023.04.018_bib70","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jaad.2008.04.006","article-title":"A\u00a0pilot quality-of-life instrument for pruritus","volume":"59","author":"Desai","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib79","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jamadermatol.2020.3071","article-title":"Validation of psychometric properties of the itch numeric rating scale for pruritus associated with prurigo nodularis: a secondary analysis of a randomized clinical trial","volume":"156","author":"Kimel","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib80","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/jdv.18221","article-title":"Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus: a systematic review of current evidence and analysis of response predictors","volume":"36","author":"Gael","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib81","first-page":"e5178","article-title":"Uremic pruritus: prevalence and impact on quality of life and depressive symptoms in hemodialysis patients","volume":"11","author":"Satti","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.jaci.2023.04.018_bib82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/jdv.15145","article-title":"The self-assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries","volume":"33","author":"Brenaut","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib83","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2018.04.044","article-title":"Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial","volume":"79","author":"Steinke","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib84","article-title":"Woad extract containing cream improves significantly dry, irritated, and pruritic skin","volume":"32","author":"Forner","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2023.04.018_bib85","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13447","article-title":"Pruritic and antipruritic colors: an exploratory pilot study","volume":"33","author":"Mueller","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2023.04.018_bib86","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2340\/00015555-3120","article-title":"Aprepitant in anti-histamine-refractory chronic nodular prurigo: a multicentre, randomized, double-blind, placebo-controlled, cross-over, phase-II trial (APREPRU)","volume":"99","author":"Tsianakas","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib87","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13555-019-0293-2","article-title":"Real-world, non-interventional, observational study of hydroxyzine hydrochloride in chronic pruritus: a prospective, non-comparative study","volume":"9","author":"Thomas","year":"2019","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaci.2023.04.018_bib88","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/jdv.16149","article-title":"Effectiveness of a music intervention on pruritus: an open randomized prospective study","volume":"34","author":"Demirtas","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib89","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/jdv.15225","article-title":"Cross-European validation of the ItchyQoL in pruritic dermatoses","volume":"33","author":"Zeidler","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib90","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaad.2020.03.049","article-title":"Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo","volume":"83","author":"Chiricozzi","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib71","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/ijms17030425","article-title":"Nocturnal pruritus: the battle for a peaceful night\u2019s sleep","volume":"17","author":"Lavery","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2023.04.018_bib72","first-page":"73","article-title":"Mirtazapine for the treatment of chronic pruritus","volume":"6","author":"Khanna","year":"2019","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.jaci.2023.04.018_bib73","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1365-2230.2006.02211.x","article-title":"Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch","volume":"31","author":"Schneider","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib74","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/bjd.13492","article-title":"Relations between the characteristics and psychological comorbidities of chronic pruritus differ between men and women: women are more anxious than men","volume":"172","author":"Stumpf","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.04.018_bib75","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1111\/jdv.15559","article-title":"Chronic pruritus patients with psychiatric and psychosomatic comorbidity are highly burdened: a longitudinal study","volume":"33","author":"Schneider","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.04.018_bib76","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.clinthera.2020.01.025","article-title":"Effects of stress on itch","volume":"42","author":"Golpanian","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaci.2023.04.018_bib77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbrc.2013.09.065","article-title":"11\u03b2-Hydroxysteroid dehydrogenase 1 contributes to the pro-inflammatory response of keratinocytes","volume":"440","author":"Itoi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2023.04.018_bib78","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3348","article-title":"Challenges in clinical research and care in pruritus","volume":"100","author":"Pereira","year":"2020","journal-title":"Acta Derm Venereol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923005699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923005699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:30:27Z","timestamp":1749270627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674923005699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0091674923005699"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2023.04.018","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical aspects and management of chronic itch","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2023.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}